NEW YORK CITY, NY / ACCESS Newswire / January 20, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Zeta Global Holdings Corp. (NYSE:ZETA) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Zeta, you […]
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Symbotic Inc. (NASDAQ:SYM) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Symbotic, you are encouraged to
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Nextracker Inc. (NASDAQ:NXT) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Nextracker, you are encouraged to
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Marqeta, Inc. (NASDAQ:MQ) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Marqeta, you are encouraged to
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ:BIOA) and certain of its senior executives for potential violations of the federal securities laws. If you invested in BioAge, you are encouraged to
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Applied Therapeutics, you are
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bioage-labs-inc-lawsuit-submission-form?prid=123957&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=123956&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your Xerox Holdings Corporation (NASDAQ:XRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/xerox-holdings-corporation-lawsuit-submission-form?prid=123955&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / January 20, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/astrazeneca-plc-lawsuit-submission-form?prid=123954&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call